Latest filing published 10 Feb 2026 for Eikon Therapeutics, Inc..
Roger M. Perlmutter sold once, on November 8, 2018: EUR 14,840,832 of Merck & Co., Inc. stock. It is the only market trade of the record and, by far, the only line carrying an amount. No purchase is recorded.
Of 10 filings, published between February 24, 2016 and February 10, 2026, 9 concern Merck, under the title Exe V-P & Pres, MRL, and 1 Eikon Therapeutics, Inc. The rest is 6 share grants, 2 option exercises and one filing of another kind.
The calendar is widely spaced: 3 filings in 2016 and 2018, then 1 in each of 2017, 2019, 2020 and 2026. The 2026 filing alone belongs to the past twelve months, and it was published on February 10, 2026. The median gap between a transaction and its filing is 2 days.
Trades by Perlmutter within 30 days of colleagues at Merck & Co., Inc. number 1, 1 and 1. All in the same direction. In the same order, the colleagues are Adam H. Schechter, Ashley Watson and Julie L. Gerberding.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations